[HTML][HTML] Marine algae-derived bioactive compounds: a new wave of nanodrugs?

F Menaa, U Wijesinghe, G Thiripuranathar… - Marine drugs, 2021 - mdpi.com
Marine algae are rich in bioactive nutraceuticals (eg, carbohydrates, proteins, minerals, fatty
acids, antioxidants, and pigments). Biotic (eg, plants, microorganisms) and abiotic factors …

Emerging theranostic nanomaterials in diabetes and its complications

Y Liu, S Zeng, W Ji, H Yao, L Lin, H Cui… - Advanced …, 2022 - Wiley Online Library
Diabetes mellitus (DM) refers to a group of metabolic disorders that are characterized by
hyperglycemia. Oral subcutaneously administered antidiabetic drugs such as insulin …

An adhesive hydrogel with “Load‐Sharing” effect as tissue bandages for drug and cell delivery

J Chen, D Wang, LH Wang, W Liu, A Chiu… - Advanced …, 2020 - Wiley Online Library
Hydrogels with adhesive properties have potential for numerous biomedical applications.
Here, the design of a novel, intrinsically adhesive hydrogel and its use in develo** internal …

A nanofibrous encapsulation device for safe delivery of insulin-producing cells to treat type 1 diabetes

X Wang, KG Maxwell, K Wang, DT Bowers… - Science translational …, 2021 - science.org
Transplantation of stem cell–derived β (SC-β) cells represents a promising therapy for type 1
diabetes (T1D). However, the delivery, maintenance, and retrieval of these cells remain a …

[HTML][HTML] Recent advances in nanocarrier-assisted therapeutics delivery systems

S Su, PM Kang - Pharmaceutics, 2020 - mdpi.com
Nanotechnologies have attracted increasing attention in their application in medicine,
especially in the development of new drug delivery systems. With the help of nano-sized …

Type 1 Diabetes Mellitus: A Review on Advances and Challenges in Creating Insulin Producing Devices

SM Rodrigues Oliveira, A Rebocho, E Ahmadpour… - Micromachines, 2023 - mdpi.com
Type 1 diabetes mellitus (T1DM) is the most common autoimmune chronic disease in young
patients. It is caused by the destruction of pancreatic endocrine β-cells that produce insulin …

[HTML][HTML] Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus

DA Domingo-Lopez, G Lattanzi, LHJ Schreiber… - Advanced drug delivery …, 2022 - Elsevier
Diabetes mellitus refers to a group of metabolic disorders which affect how the body uses
glucose impacting approximately 9% of the population worldwide. This review covers the …

Hydrogels in emerging technologies for type 1 diabetes

S Fuchs, AU Ernst, LH Wang, K Shariati… - Chemical …, 2020 - ACS Publications
Type 1 diabetes therapies that afford tighter glycemic control in a more manageable and
painless manner for patients has remained a central focus of next-generation diabetes …

Biomaterials for personalized cell therapy

AL Facklam, LR Volpatti, DG Anderson - Advanced materials, 2020 - Wiley Online Library
Cell therapy has already had an important impact on healthcare and provided new
treatments for previously intractable diseases. Notable examples include mesenchymal …

A Glucose‐Responsive Cannula for Automated and Electronics‐Free Insulin Delivery

S Fuchs, JS Caserto, Q Liu, K Wang… - Advanced …, 2024 - Wiley Online Library
Automated delivery of insulin based on continuous glucose monitoring is revolutionizing the
way insulin‐dependent diabetes is treated. However, challenges remain for the widespread …